CONMED Corp — Director's Dealing 2020

Aug 3, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2020-07-31

Reporting Person: SHAGORY PETER K (EVP, STRAT & CORP DEVT)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-31	Common Stock	M	4440	$39.87	Acquired	6301	Direct
2020-07-31	Common Stock	S	4440	$84.567	Disposed	1861	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-07-31	Options To Purchase Common Stock	$39.87	M	4440	Disposed	2026-03-01	Common Stock (4440)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.52 to $86.085. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.

F2: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period